Novel Hepatitis B Virus Genotype A Subtyping Assay That Distinguishes Subtype Aa from Ae and Its Application in Epidemiological Studies
-
- Izumi Hasegawa
- Department of Clinical Molecular Informative Medicine
-
- Yasuhito Tanaka
- Department of Clinical Molecular Informative Medicine
-
- Anna Kramvis
- MRC/CANSA/University Molecular Hepatology Research Unit, Department of Medicine, University of the Witwatersrand, Johannesburg, South Africa
-
- Takanobu Kato
- Department of Clinical Molecular Informative Medicine
-
- Fuminaka Sugauchi
- Department of Internal Medicine and Molecular Science, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan
-
- Subrat K. Acharya
- Sub Bagian Hepatologi, Department of Gastroenterology, All India Institute of Medical Sciences, New Delhi, India
-
- Etsuro Orito
- Department of Internal Medicine and Molecular Science, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan
-
- Ryuzo Ueda
- Department of Internal Medicine and Molecular Science, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan
-
- Michael C. Kew
- MRC/CANSA/University Molecular Hepatology Research Unit, Department of Medicine, University of the Witwatersrand, Johannesburg, South Africa
-
- Masashi Mizokami
- Department of Clinical Molecular Informative Medicine
抄録
<jats:title>ABSTRACT</jats:title><jats:p>The eight genotypes of hepatitis B virus (HBV) have different geographical distributions, virological characteristics, and clinical manifestations. A unique subtype of HBV genotype A (HBV/A) was reported in sub-Saharan Africa, raising the possibility that patients infected with this subtype (HBV/Aa [“a” for African and Asian]) may have different clinical outcomes than other HBV/A isolates (HBV/Ae [“e” for European]). Comparison between 30 HBV/Aa and 30 HBV/Ae isolates indicated that almost all HBV/Ae isolates had G at nucleotide (nt) 1809 and C at nt 1812, whereas HBV/Aa isolates had T1809/T1812. Taking advantage of these two single nucleotide polymorphisms (SNPs), a novel subtype-specific PCR assay in the X/precore/core region was developed. This assay was combined with a restriction fragment length polymorphism assay using BglII in a different region (nt 1984 to 1989), which has a SNP distinguishing HBV/Aa from HBV/Ae, resulting in 100% specificity for the combined assay. Application of the subtyping assay using sera from 109 paid donors in the United States indicated significantly different distributions of HBV/A subtypes among races; African-Americans, Caucasians, and Hispanics had HBV/Ae, whereas Asians had mainly HBV/Aa, suggesting that the HBV/Aa isolates may have been imported by recent immigration from Asia. In conclusion, the specificity and sensitivity of the combined subtyping assay were confirmed, and its usefulness was demonstrated in a practical context.</jats:p>
収録刊行物
-
- Journal of Virology
-
Journal of Virology 78 (14), 7575-7581, 2004-07-15
American Society for Microbiology
- Tweet
詳細情報 詳細情報について
-
- CRID
- 1362544419081685760
-
- NII論文ID
- 30020800215
-
- ISSN
- 10985514
- 0022538X
- http://id.crossref.org/issn/0022538X
-
- データソース種別
-
- Crossref
- CiNii Articles